التفاصيل البيبلوغرافية
| العنوان: |
2194 Symptomatic Recurrence of Endometiomata Following Plasmajet Treatment. |
| المؤلفون: |
Gherghe, M, Bjornsson, S, Hardwick, C |
| المصدر: |
Journal of Minimally Invasive Gynecology; Nov2019 Supplement, Vol. 26, pS188-S188, 1p |
| مستخلص: |
The current recommended treatment of endometriomata is surgical excision. Our study is assessing recurrence rates of endometrioma following plasma energy ablation treatment. 64 endometriomata were treated in 49 consecutive patients identified retrospectively from theatre records of a single operating surgeon, from January 2013 to December 2017. Electronic hospital records were used for data collection and to search for re-attendance for imaging or gynecology review within the whole health board. The maximum time from treatment to clinical review was 66 months. All Patients included in study were treated using plasma energy device, PlasmaJet. University Hospital. Forty-nine consecutive patients, identified retrospectively. Endometriomata ablation using plasma energy device. Mean age at surgery was 35 year (+/- 5.8) with a recorded BMI of 26 (+/- 3.8). Median recurrence of symptoms of pain was 20 months. Symptomatic recurrence of endometriomata diagnosed within the health board was 6.2% when looking at total number of cysts treated, with an average time of 19 months from treatment to recurrence. Bilateral endometriomata predicted recurrence compared to unilateral disease with an OR 3.02, RR2.6. Women under the age of 35 years were more likely to be diagnosed with recurrence of endometriomata than women over 35 years with an OR 3.3, RR2.83. Secondary outcomes recorded were recurrence of pain, dysmenorrhoea and peri-operative complications. Recurrence of endometrioma in our study is comparable with published rate of recurrence after excision treatment (14-17%). Plasma energy ablation may have lower recurrence rates than other ablation techniques. Formal studies with long term follow up are required. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Minimally Invasive Gynecology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Supplemental Index |
